Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 96 | 106 | 73 | 124 | 67 |
| Cost of Goods | 29 | 46 | 24 | 32 | 7 |
| Gross Profit | 68 | 60 | 49 | 92 | 60 |
| Operating Expenses | 522 | 388 | 303 | 444 | 316 |
| Operating Income | -426 | -282 | -230 | -320 | -249 |
| Interest Expense | 30 | 12 | 51 | 128 | 73 |
| Other Income | 2 | 4 | 0 | 75 | 0 |
| Pre-tax Income | -454 | -290 | -281 | -372 | -322 |
| Net Income Continuous | -454 | -290 | -281 | -372 | -322 |
| Net Income | $-454 | $-290 | $-281 | $-372 | $-322 |
| EPS Basic Total Ops | -0.06 | -0.05 | -0.04 | -0.05 | -0.04 |
| EPS Basic Continuous Ops | -0.06 | -0.04 | -0.04 | -0.05 | -0.04 |
| EPS Diluted Total Ops | -0.06 | -0.05 | -0.04 | -0.05 | -0.04 |
| EPS Diluted Continuous Ops | -0.06 | -0.04 | -0.04 | -0.05 | -0.04 |
| EBITDA(a) | $-397 | $-271 | $-183 | $-242 | $-178 |